Taiko Pharmaceutical Co.,Ltd. (4574.T) - Stock Prices, Stock Peers & Analysis

Home
4574.T

Company Name	Taiko Pharmaceutical Co.,Ltd.
Symbol	4574.T
Currency	JPY
Price	409
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	20,529,227,799
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	263 - 495
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Takashi Shibata
Website	https://www.seirogan.co.jp

An error occurred while fetching data.

About Taiko Pharmaceutical Co.,Ltd.

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator